From: Maternal Near Miss and quality of care in a rural Rwandan hospital
Interventions | n (%) |
---|---|
Prevention of PPH | |
Target population: women giving birth in health facilities | 4131 |
Oxytocin | 3862 (93.5 %) |
Treatment of severe PPH | |
Target population: women with severe PPH | 134 |
Oxytocin | 97 (72.4 %) |
Ergometrine | 105 (78.4 %) |
Misoprostol | 44 (32.8 %) |
Other uterotonics | 62 (46.3 %) |
Removal of retained products | 18 (13.4 %) |
Artery ligation | 7 (5.2 %) |
Hysterectomy | 4 (2.9 %) |
Abdominal packing | 8 (5.9 %) |
Cases with SMO | 52 (38.8 %) |
Mortality | 3 (2.2 %) |
Anticonvulsants for Eclampsia | |
Target population: women with eclampsia | 53 |
Magnesium sulfate | 52 (98.1 %) |
Other anticonvulsant | 8 (15.1 %) |
Any anticonvulsant | 53 (100 %) |
Cases with SMO | 24 (50.9 %) |
Mortality | 4 (7.5 %) |
Prevention of cesarean-related infection | |
Target population: women undergoing cesarean | 1442 |
Prophylactic antibiotic during cesarean | 1409 (97.6 %) |
Treatment for sepsis | |
Target population: women with sepsis | 38 |
Parenteral therapeutic antibiotics | 18 (47.4 %) |
Cases with SMO | 6 (15.8 %) |
Mortality | 2 (5.3 %) |
Ruptured uterus | |
Target population: women with ruptured uterus | 15 |
Laparotomy after 3 h of hospital stay | 2 (13.3 %) |
Cases with SMO | 12 (80.0 %) |
Mortality | 1 (6.7 %) |